We hypothesize that the predominant adrenergic cell type of neuroblastomas must maintain suppression of Notch signaling, and that PDXs are enriched for adrenergic cell type and thus DLL3 overexpression (14–16). The gene discussed is DLL3; the disease is neuroblastoma.